Pantera is a joint venture between IBA (Ion Beam Applications S.A.), the world leader in particle accelerator technology, and the Belgian Nuclear Research Centre SCK CEN, world leader in reactor produced medical isotopes. Pantera will secure the large-scale production of Ac-225 (actinium-225), one of the most promising alpha-emitting radioisotopes to fight cancers. By working towards this large-scale production, Pantera’s ultimate goal is to improve the accessibility of future innovative cancer therapies based on Ac-225.